PULM
Pulmatrix, Inc.
Key Financials
EPS (Diluted)
$-1.41
↑ 46.2%
Net Income
$-5162000
↑ 46.0%
Total Assets
$4.1M
↓ 58.4%
Operating Income
$-5169000
↑ 47.1%
Shareholders' Equity
$3.8M
↓ 57.4%
Total Liabilities
$329000.00
↓ 67.0%
Long-term Debt
$3.2M
0.0%
Operating Cash Flow
$-5433000.00
↑ 49.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| D | 4/15/2026 | View on SEC |
| 8-K | 3/27/2026 | View on SEC |
| 425 | 3/26/2026 | View on SEC |
| 8-K | 3/2/2026 | View on SEC |
| 10-K | 2/26/2026 | View on SEC |
| 8-K | 2/26/2026 | View on SEC |
| 8-K | 12/18/2025 | View on SEC |
| 10-Q | 10/16/2025 | View on SEC |
| 8-K | 10/16/2025 | View on SEC |
| 10-Q | 8/6/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PULM |
| Company Name | Pulmatrix, Inc. |
| CIK | 1574235 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (888) 355-4440 |